Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries H Lundbeck A/S (OP: HLUKF ) N/A UNCHANGED Last Price Updated: 3:18 PM EDT, Jun 8, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about H Lundbeck A/S Is a Victory for Its Rivals Bad News for Axsome Therapeutics? May 17, 2023 The biopharmaceutical company's shares have soared during the past year. Via The Motley Fool 3 Biotech Stocks Under $10 to Add to Your Buy List April 26, 2022 These biotech stocks to buy are all profitable, which is important for investors looking to reduce their investment risk. Via InvestorPlace Lundbeck Out Licenses Flopped Alzheimer's Drug In Wake Of Biogen's Controversial Success With Aducanumab July 02, 2021 Privately-held Denovo Biopharma LLC has in-licensed global rights for idalopirdine from H. Lundbeck A/S (OTC: HLUYY) for all indications. The deal... Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
